Towa Pharmaceutical Co., Ltd. logo

Towa Pharmaceutical Co., Ltd. (6QC)

Market Open
11 Aug, 06:03
XFRA XFRA
19. 70
-0.2
-1.005%
971.87M Market Cap
- P/E Ratio
80% Div Yield
200 Volume
- Eps
19.9
Previous Close
Add Transaction
Day Range
19.7 19.7
Year Range
15.2 23.6
Want to track 6QC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6QC trading today lower at €19.7, a decrease of -1.005% from yesterday's close, completing a monthly decrease of -2.4752% or -€0.5. Over the past 12 months, 6QC stock gained 2.0725%.
6QC pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of €40.
The last earnings report, released on May 07, 2026, missed the consensus estimates by -113.89%. On average, the company has fell short of earnings expectations by -73.7233%, based on the last three reports.
Towa Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Mar 27, 2019.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on JPX (JPY).

6QC Chart

People also search for

P22
Nagase & Co., Ltd.
6.7
0%
1U3
Bic Camera Inc.
9.15
-0.5435%
3S5
Red Star Macalline Group Corporation Ltd.
0.12
0%
Fufeng Group Ltd.
0.55
-0.9009%
31S
Stella International Holdings Ltd.
1.54
-0.6452%

Towa Pharmaceutical Co., Ltd. (6QC) FAQ

What is the stock price today?

The current price is €19.70.

On which exchange is it traded?

Towa Pharmaceutical Co., Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 6QC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 80%.

What is its market cap?

As of today, the market cap is 971.87M.

Has Towa Pharmaceutical Co., Ltd. ever had a stock split?

Towa Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Mar 27, 2019.

Towa Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Itsuro Yoshida CEO
XFRA Exchange
JP3623150004 ISIN
JP Country
4,588 Employees
29 Sep 2026 Last Dividend
27 Mar 2019 Last Split
- IPO Date

Overview

Towa Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company based in Osaka, Japan, with a long history dating back to 1951. Engaged primarily in the research, development, production, and sale of ethical drugs, active pharmaceutical ingredients, and intermediates, Towa Pharmaceutical Co., Ltd. stands out in the Japanese pharmaceutical industry. With a focus on serving the healthcare sector, the company leverages its expertise to contribute to therapeutic areas, including the digestive and nervous systems, and allergic diseases, among others. Moreover, its commitment to innovation extends beyond pharmaceuticals, as it also encompasses IT services related to healthcare and disease risk testing services, highlighting its multifaceted approach to improving patient care and health outcomes.

Products and Services

  • Ethical Drugs
  • Specializing in the development and distribution of ethical drugs, Towa Pharmaceutical Co., Ltd. focuses on medications that require a physician's prescription. Their products cover various therapeutic areas such as digestive system disorders, nervous system ailments, and allergic diseases, demonstrating the company's commitment to addressing a wide range of medical needs within the healthcare landscape.

  • Active Pharmaceutical Ingredients (APIs) and Intermediates
  • A key player in the pharmaceutical industry, the company manufactures and provides high-quality active pharmaceutical ingredients and intermediates. This supports not only its own drug development endeavors but also the wider pharmaceutical industry, facilitating the creation of a range of medications and treatments.

  • Vitamins, Antibiotics, and Oncology Products
  • Towa Pharmaceutical Co., Ltd. offers an array of vitamins and antibiotic treatments, catering to the essential health needs of diverse patient demographics. Furthermore, the company is actively involved in the oncology sector, providing critical cancer treatment solutions that contribute significantly to patient care in this challenging therapeutic area.

  • IT Services Related to Healthcare
  • Recognizing the increasingly vital role of information technology in healthcare, Towa Pharmaceutical extends its offerings to include IT services specifically tailored to the healthcare sector. This entails developing and implementing systems that enhance the efficiency of healthcare delivery and patient care management.

  • Disease Risk Testing Services
  • Amid growing awareness of preventative healthcare, the company offers disease risk testing services. These services aim to identify the potential risk of diseases early on, thereby enabling individuals to take proactive steps towards preventing the onset of illness through timely interventions.

  • Research and Development of Diagnostic Drugs
  • Investing in the research and development of diagnostic drugs signifies Towa Pharmaceutical Co., Ltd.'s dedication to advancing medical science. By focusing on diagnostics, the company underlines the importance of accurate, early detection in the effective treatment of diseases, improving patient outcomes.

  • Health Food, Pharmaceuticals, General Food, and Other Product Development and OEM Manufacturing
  • In addition to its pharmaceutical products, the company engages in the planning, development, and OEM (Original Equipment Manufacturer) manufacturing of health food, general food items, and other related products. This diversification illustrates the company's versatile approach to health and wellness, extending its impact beyond traditional pharmaceuticals.

Contact Information

Address: 2-11, Shinbashi-cho
Phone: 81 6 6900 9100